Net Cash Provided by (Used in) Operating Activities |
768K |
USD |
+1.86% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-65K |
USD |
+93.5% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
6.6M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
241K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
200K |
USD |
-57.9% |
Mar 31, 2024 |
Q1 2024 |
Depreciation |
21K |
USD |
0% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-16K |
USD |
+30.4% |
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
8K |
USD |
+14.3% |
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
861K |
USD |
+8.03% |
Mar 31, 2024 |
Q1 2024 |
Current State and Local Tax Expense (Benefit) |
248K |
USD |
+19.2% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
637K |
USD |
+14.4% |
Dec 31, 2023 |
Q4 2023 |
Deferred State and Local Income Tax Expense (Benefit) |
5K |
USD |
+150% |
Dec 31, 2023 |
Q4 2023 |